SCHEMBL6783071

SCHEMBL6783071

COc1cc2c(c(OC)c1OC)CCC(/C=C/C(=O)O)=C2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.51
ALDH1A1 P00352 7/20 0.51
HPGD P15428 4/20 0.51
HSD17B10 Q99714 2/20 0.51
HTR1A P08908 2/20 0.51
HTR2C P28335 1/20 0.51
SMN1; SMN2 Q16637 4/20 0.41
PKM P14618 2/20 0.41
PTGS1 P23219 1/20 0.41
PTGS2 P35354 1/20 0.41
ALOX15 P16050 1/20 0.40
MAPK1 P28482 1/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA3 P07451 1/20 0.39
CSNK2A2 P19784 1/20 0.39
CA4 P22748 1/20 0.39
CA6 P23280 1/20 0.39
CA5A P35218 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6794084 0.82 ALDH1A1 (0.55) KDM4EALDH1A1HPGDHSD17B10PTGS2
SCHEMBL6793154 0.80 LMNA (0.40) KDM4EALDH1A1SMN1; SMN2LMNAMEN1
SCHEMBL4269325 0.80 KDM4E (0.47) KDM4EALDH1A1HPGDHSD17B10HTR1A
SCHEMBL4269322 0.80 KDM4E (0.47) KDM4EALDH1A1HPGDHSD17B10HTR1A
SCHEMBL5570694 0.79 KDM4E (0.51) KDM4EALDH1A1HPGDHSD17B10HTR1A
SCHEMBL4645198 0.79 KDM4E (0.51) KDM4EALDH1A1HPGDHSD17B10HTR1A
SCHEMBL7814302 0.76 TPMT (0.41) KDM4EALDH1A1HPGDHSD17B10HTR1A
SCHEMBL6787806 0.76 KDM4E (0.48) KDM4EALDH1A1HPGDHSD17B10HTR1A
Methylene Chloride SCHEMBL28111275 0.76 LMNA (0.36) KDM4ESMN1; SMN2LMNAMEN1KMT2A
Pyrrole SCHEMBL4270409 0.73 ALDH1A1 (0.40) KDM4EALDH1A1HPGDHSD17B10HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6828316-B2 Antiallergens KOWA CO., LTD. (JP) 2004-12-07 US disclosed
US-20020042414-A1 Diamide compound and medicine containing the same KOWA CO., LTD. (JP) 2002-04-11 US disclosed
US-6340682-B1 FOR THERAPY OF ALLERGIC IMMUNOLOGICAL DISEASE IS SELECTED FROM ASTHMA, ALLERGIC RHINITIS, INFLAMMATORY LARGE BOWEL DISEASE OR CONTACT DERMATITIS KOWA CO., LTD. (JP) 2002-01-22 US disclosed
EP-0926138-A1 DIAMIDE COMPOUNDS AND DRUGS CONTAINING THE SAME KOWA CO. LTD. (JP) 1999-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020042414-A1 Diamide compound and medicine containing the same HRH4, HRH2, HRH1 KDM4E 562/4885ALDH1A1 836/4885HPGD 884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.